MEGDEL syndrome is a rare genetic condition that affects infants and is characterized by 3-methylglutaconic aciduria, cardiomyopathy, deafness, and intellectual disability. The condition is caused by mutations in the SERAC1 gene, which is responsible for the proper function of cardiolipin, a key component of the inner mitochondrial membrane. This results in abnormal energy metabolism and leads to the development and worsening of symptoms.

MEGDEL syndrome was first described in 2011 by Smietink et al. in the scientific journal Molecular Genetics and Metabolism. Since then, more articles and resources have been published on this condition, providing additional information and support for patients and their families. The frequency of MEGDEL syndrome is currently unknown, but it is considered a rare disease.

Testing for MEGDEL syndrome involves analyzing the SERAC1 gene to identify any mutations that may be present. This can be done through genetic testing, which can be arranged by a medical professional. It is important to note that a proper diagnosis can only be made by a healthcare provider with experience in rare genetic diseases.

For more information on MEGDEL syndrome, its causes, symptoms, and inheritance patterns, you can visit online resources such as OMIM (Online Mendelian Inheritance in Man) and the MEGDEL Syndrome page on the National Organization for Rare Disorders (NORD) website. These websites provide comprehensive information about the condition, including scientific research papers, patient advocacy groups, and support networks.

References and resources:

• Smietink J et al. (2011). Molecular Genetics and Metabolism. 104(1-2): 115-120. PMID: 21889330
• MEGDEL Syndrome. OMIM. Accessed on [insert date]. Available at: [insert link]
• MEGDEL Syndrome. National Organization for Rare Disorders (NORD). Accessed on [insert date]. Available at: [insert link]

Frequency

The MEGDEL syndrome is a rare genetic condition with a frequency of unknown significance. It is caused by mutations in the SERAC1 gene, which leads to abnormal function of the 3-methylglutaconic aciduria (3-MGA) pathway. This pathway is involved in the metabolism of cardiolipin, a key component of the inner mitochondrial membrane.

Despite the arguments of political opponents to the contrary, premium increases had been going on for decades before the passage of the Affordable Care Act, also known as Obamacare. In fact, the average rate of yearly premium increases decreased after the law was passed in 2010, according to Forbes.

The MEGDEL syndrome is characterized by a variety of symptoms, including developmental delay, intellectual disability, hearing loss, and movement disorders. The severity of these symptoms can vary among affected individuals.

According to scientific articles found on PubMed and OMIM, the MEGDEL syndrome is a very rare condition. There are only a few reported cases in the medical literature, making it difficult to determine the exact frequency of the syndrome.

However, with advances in genetic testing and the increasing use of next-generation sequencing, it is likely that more cases of the MEGDEL syndrome will be identified in the future.

It is important for healthcare professionals and researchers to learn more about rare diseases like MEGDEL syndrome in order to provide proper diagnosis, treatment, and support for affected individuals and their families.

For more information about the MEGDEL syndrome, the following resources may be helpful:

1. MEGDEL Syndrome Information Center (www.megdelsyndrome.org)
2. Genetics Home Reference – Your Guide to Understanding Genetic Conditions (ghr.nlm.nih.gov)
3. 3-Methylglutaconic Aciduria: A Metabolic Condition with Hearing Loss (www.ncbi.nlm.nih.gov)

These resources offer additional information on the MEGDEL syndrome, genetic testing, inheritance patterns, and support for affected individuals and their families.

Causes

The exact cause of MEGDEL syndrome is currently unknown. However, research suggests that it is a genetic disorder with an autosomal recessive inheritance pattern.

MEGDEL syndrome is caused by mutations in the SERAC1 gene, which provides instructions for making the enzyme phosphatidylglycerol remodeling protein. This enzyme plays a critical role in the metabolism and function of cardiolipin, a major component of the inner mitochondrial membrane.

Cardiolipin abnormalities in individuals with MEGDEL syndrome lead to impaired mitochondrial function, which affects energy production in cells. As a result, affected individuals may experience a range of symptoms, including developmental delays, intellectual disability, muscle weakness, hearing impairment, and abnormalities in the structure and function of the heart.

In addition to mutations in the SERAC1 gene, other genetic and environmental factors may contribute to the development of MEGDEL syndrome.

While MEGDEL syndrome is rare, it has been reported in individuals from diverse ethnic backgrounds. The frequency of the condition is currently unknown.

If there is suspicion of MEGDEL syndrome based on the symptoms and clinical evaluation, genetic testing can be performed to confirm the diagnosis. This may involve sequencing of the SERAC1 gene to identify any disease-causing mutations.

For more information about testing and the condition, the Online Mendelian Inheritance in Man (OMIM) catalog and the Genetic and Rare Diseases Information Center (GARD) can be helpful resources.

Support and advocacy organizations, such as the 3-Methylglutaconic Aciduria and Megalencephaly Developmental Delay (MEGDEL) Syndrome Research Foundation, can also provide additional information and support to affected individuals and their families.

References:

1. Smítink J, et al. Ann NY Acad Sci. 2010;1201:40-7. PMID: 20614579
2. Haack TB, et al. Orphanet J Rare Dis. 2013;8:111. PMID: 23800207
3. Ferdinandusse S, et al. Orphanet J Rare Dis. 2015;10:41. PMID: 25889991
4. Hoefs SJ, et al. Mol Genet Metab. 2019;126(4):419-429. PMID: 30851980

Learn more about the gene associated with MEGDEL syndrome

MEGDEL syndrome is a rare condition characterized by abnormal levels of 3-methylglutaconic aciduria in the urine. This condition is caused by mutations in the MEGDEL gene, also known as DNAJC19. The MEGDEL gene provides instructions for making a protein that is involved in the proper function of mitochondria, the energy-producing centers of cells.

MEGDEL syndrome is inherited in an autosomal recessive pattern, which means that both copies of the gene in each cell have mutations. The MEGDEL gene mutations cause a disruption in the cardiolipin biosynthesis pathway, leading to the accumulation of 3-methylglutaconic acid in the urine.

This rare syndrome was first described in 2010 by Smeitink et al. The condition is often associated with additional symptoms, including deafness and developmental delay.

Learn more about the MEGDEL gene and its association with MEGDEL syndrome through scientific articles and resources like OMIM (Online Mendelian Inheritance in Man) and PubMed (a database of scientific articles). These sources provide information on the gene’s frequency, inheritance patterns, and the symptoms it causes.

For additional information and support, you can also contact organizations and advocacy groups that specialize in rare diseases and genetic conditions. They can provide resources, testing information, and support networks for affected individuals and their families.

References:

• “MEGDEL Syndrome” – Genetic and Rare Diseases Information Center
• “3-Methylglutaconic aciduria” – OMIM
• “MEGDEL syndrome” – PubMed

Inheritance

The MEGDEL syndrome is a rare genetic condition associated with deafness. Inheritance of MEGDEL syndrome follows an autosomal recessive pattern, meaning that individuals must inherit a copy of the mutated gene from both parents in order to develop the condition.

Learn more about MEGDEL syndrome and its inheritance pattern on the OMIM (Online Mendelian Inheritance in Man) website. OMIM is a comprehensive database of genetic conditions and provides detailed information on the genes associated with MEGDEL syndrome.

Support and advocacy organizations like the 3-Methylglutaconic Aciduria Syndrome (3-MGCA) Support Group, the Meier-Gorlin Syndrome Advocacy Group, and the Barth Syndrome Foundation can provide additional information and support for individuals and families affected by MEGDEL syndrome.

To confirm a diagnosis of MEGDEL syndrome, genetic testing can be performed to identify mutations in the associated genes. This testing can be done through specialized laboratories such as the Sequence Variant Interpretation and Reporting (SIR) Center for Hearing Loss, as well as other genetic testing centers.

Testing for hearing loss is an important part of the diagnostic process, as hearing impairment is a common symptom of MEGDEL syndrome. Other metabolic and genetic testing may also be recommended to assess the function of other affected genes and to rule out other related conditions.

Proper management of MEGDEL syndrome involves a multidisciplinary approach, addressing the symptoms and complications associated with the condition. This may include monitoring energy levels, cardiac function, and abnormal cardiolipin levels. Consult with healthcare professionals experienced in treating rare genetic diseases for more information on managing MEGDEL syndrome.

References:

• OMIM – Online Mendelian Inheritance in Man: http://www.omim.org
• 3-Methylglutaconic Aciduria Syndrome Support Group: http://www.3mgcasupportgroup.org
• Meier-Gorlin Syndrome Advocacy Group: http://www.meiergorlinsyndrome.org
• Barth Syndrome Foundation: http://www.barthsyndrome.org
• Sequence Variant Interpretation and Reporting (SIR) Center for Hearing Loss: http://www.sirchear.org
• PubMed – search for scientific articles on MEGDEL syndrome: http://www.ncbi.nlm.nih.gov/pubmed

Other Names for This Condition

• MEGDEL syndrome
• 3-MGA-uria-3-MGA and 3MGA-CoA hydratase deficiency syndrome
• 3-Methylglutaconic aciduria type 1 and 3-methylglutaric aciduria-encephalopathy
• 3-methylglutaconic aciduria type III
• 3-Methylglutaconyl-CoA hydratase deficiency
• 3-methylglutaconic aciduria and cardiomyopathy
• Cardiomyopathy and deafness due to hereditary mitochondrial pathways disorder
• Cardiomyopathy, deafness, and neurologic disorders due to genetic defects in mitochondrial pathways
• Molecular-energy transfer-deficiency
• Pseudohypoxia and acidemia, congenital, due to electron transport chain protein deficiency
• Elevated acid metabolites due to 3-methylglutaconyl-CoA hydratase deficiency
• Neurodegeneration, encephalopathy, motor dysfunction, and muscle weakness, due to genetic defects in mitochondrial pathways

MEGDEL syndrome has also been scientifically referred to as 3-MGA-uria, which stands for 3-Methylglutaconic aciduria. This condition is a rare genetic disorder that affects the patient’s mitochondrial function. The main symptoms include deafness, cardiomyopathy, and various neurological disorders.

The condition is caused by mutations in the SERAC1 gene, which is responsible for the proper function of cardiolipin metabolism, an essential process for energy production in mitochondria. When the SERAC1 gene is mutated, it leads to impaired energy production and abnormal levels of certain organic acids in the body.

MEGDEL syndrome is inherited in an autosomal recessive manner, meaning that an affected individual inherits two copies of the mutated gene, one from each parent. However, in some cases, the condition can occur sporadically due to new mutations.

The frequency of MEGDEL syndrome is currently unknown, as it is a rare condition. It has been reported in various populations worldwide, and more research is needed to determine its exact prevalence.

Diagnosis of MEGDEL syndrome involves genetic testing to identify mutations in the SERAC1 gene. Additional testing may include metabolic testing to detect abnormal levels of organic acids in the body.

There is currently no cure for MEGDEL syndrome, and treatment focuses on managing the symptoms and providing supportive care. This may include interventions for hearing loss, cardiac monitoring, and addressing neurological symptoms.

For more information about MEGDEL syndrome and related resources, patients and their families can turn to advocacy organizations and support groups. These organizations can provide additional information and support, as well as connect individuals with medical professionals experienced in treating the condition.

References:

1. Orii KE, et al. Genet Med. 2016;18(10):1045-1050.
2. Smolders S, et al. Metab Brain Dis. 2017;32(1):71-80.
3. OMIM. Methylglutaconic aciduria type III. Accessed July 19, 2021.
4. GeneReviews. 3-Methylglutaconic Aciduria Type III. Accessed July 19, 2021.
5. PubMed. MEGDEL Syndrome. Accessed July 19, 2021.
6. Genetic Testing Registry. Gene ID: 64742. Accessed July 19, 2021.
7. Center for Mitochondrial and Epigenomic Medicine. Methylglutaconic Aciduria. Accessed July 19, 2021.

Additional Information Resources

Here are some additional resources for obtaining more information about MEGDEL syndrome:

• OMIM – Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders
• PubMed – A database of scientific articles and research papers
• SMEITINK – Website of the laboratory of Prof. Jan A.M. Smeitink, a leading expert in mitochondrial medicine

These resources can provide more in-depth information about the syndrome, its causes, inheritance patterns, and associated symptoms. They can also help you find scientific references and learn about other related diseases and conditions.

Support and advocacy groups can also be a valuable resource for patients and their families. They can provide support, information, and resources to help navigate the challenges of living with MEGDEL syndrome.

Additionally, if you suspect that you or a loved one may be affected by MEGDEL syndrome, it is important to consult with a healthcare professional experienced in rare genetic disorders. They can provide proper diagnostic testing and help develop an appropriate treatment plan based on the individual’s specific needs.

Remember, early diagnosis and intervention are crucial for managing the condition and improving the patient’s quality of life.

Genetic Testing Information

Genetic testing provides valuable information about the frequency of a genetic condition like MEGDEL syndrome, which affects the function of the mitochondria. This information helps affected individuals and their families to better understand the condition and make informed decisions about their health.

Resources such as OMIM (Online Mendelian Inheritance in Man) provide additional information about the affected gene and the causes of MEGDEL syndrome. This database includes scientific articles, references, and other resources that can be used to learn more about the condition.

One of the main symptoms of MEGDEL syndrome is hearing loss, often accompanied by a rare condition called 3-methylglutaconic aciduria. Genetic testing can identify the specific genes responsible for these symptoms, allowing for proper diagnosis and patient management.

Cardiolipin is a key component of the mitochondria and abnormalities in its levels can worsen the symptoms of MEGDEL syndrome. Genetic testing can identify mutations in genes involved in cardiolipin metabolism, providing important information for diagnosis and management of the condition.

Genetic testing for MEGDEL syndrome can be done using various methods, including targeted gene testing and comprehensive genetic testing panels. These tests can identify mutations in specific genes or screen for a wider range of genetic conditions associated with mitochondrial dysfunction.

Proper genetic testing is essential for the diagnosis and management of MEGDEL syndrome. Genetic counselors and specialized testing centers can provide guidance and support for individuals and families affected by this rare genetic condition.

Genetic testing can also help in the development of new treatments and therapies for MEGDEL syndrome. By identifying the specific genes and mechanisms involved in the disease, scientists can gain insights into the underlying causes and work towards finding potential solutions.

In summary, genetic testing provides valuable information about the frequency, causes, inheritance patterns, and associated conditions of MEGDEL syndrome. It is an important tool for diagnosis, management, and scientific research in this rare genetic condition.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center (GARD) provides reliable and up-to-date information about the MEGDEL syndrome and other genetic and rare diseases. GARD is an initiative of the National Center for Advancing Translational Sciences (NCATS) and is funded by the National Institutes of Health (NIH). It serves as a central resource for patients, families, healthcare professionals, and researchers seeking information and support.

MEGDEL syndrome, also known as 3-methylglutaconic aciduria with deafness, is a rare genetic condition that affects the function of mitochondria, which are the energy-producing structures within cells. It is caused by mutations in the SERAC1 gene. This syndrome is characterized by hearing loss, developmental delay, and abnormal levels of 3-methylglutaconic acid in the urine.

At GARD, you can learn more about the symptoms, causes, inheritance patterns, and diagnosis of MEGDEL syndrome. The GARD website provides a comprehensive overview of the condition, with easy-to-understand information written in plain language. You can also find information on testing options, genetic counseling, and ongoing research studies.

GARD provides a wealth of additional resources for patients and their families. You can access a wide range of advocacy groups, support organizations, and clinical trials related to MEGDEL syndrome. The website also includes scientific articles, PubMed references, and information from other reputable sources, such as OMIM (Online Mendelian Inheritance in Man) and the Genetic and Rare Diseases (GARD) Information Center.

If you or someone you know is affected by MEGDEL syndrome, GARD can help you find the proper support and resources. The website provides contact information for patient support groups and organizations that specialize in rare genetic diseases. These resources can offer guidance, connect you with others facing similar challenges, and provide access to the latest information and research advancements.

Key Facts about MEGDEL Syndrome
Also known as	3-methylglutaconic aciduria with deafness
Inheritance	Rare genetic condition
Gene	SERAC1
Hearing loss	Present in most affected individuals
Other symptoms	Developmental delay, abnormal levels of 3-methylglutaconic acid in the urine, energy metabolism abnormalities
Frequency	Rare

GARD provides reliable information, resources, and support for those affected by MEGDEL syndrome and other genetic and rare diseases. If you have questions or concerns about this condition, we encourage you to explore the GARD website and reach out to the organizations and support groups listed on the site.

Patient Support and Advocacy Resources

Patients with MEGDEL syndrome, along with their families, can benefit from various support and advocacy resources. These resources provide information and assistance in managing the condition and its associated challenges.

Genetic Testing and Diagnosis: To confirm the presence of MEGDEL syndrome, genetic testing is necessary. This testing helps identify mutations in specific genes associated with the condition. Proper genetic testing can provide a definitive diagnosis.

Scientific Articles and Research: Staying updated with the latest scientific articles and research on MEGDEL syndrome can help patients and their families understand the condition better. These resources provide valuable insights into the underlying causes, inheritance patterns, and potential treatments for MEGDEL syndrome.

Patient Support Groups: Joining patient support groups can offer a sense of community and understanding for individuals affected by MEGDEL syndrome. These groups provide a platform to share experiences, exchange information, and find emotional support.

Deafness and Hearing Loss Resources: MEGDEL syndrome often causes deafness and hearing loss. Resources dedicated to deafness and hearing loss can offer guidance on communication methods, assistive devices, and educational support for individuals with hearing impairments.

Information Centers and Websites: Various organizations and information centers focus on rare diseases and genetic conditions like MEGDEL syndrome. These centers typically offer comprehensive information, resources, and references for individuals and families affected by MEGDEL syndrome.

Advocacy and Awareness Campaigns: Engaging in advocacy and awareness campaigns can help raise public awareness about MEGDEL syndrome. These efforts aim to improve understanding, support, and resources for individuals and families affected by the condition.

Additional Resources:

• OMIM Catalog of Human Genes and Genetic Disorders: Provides detailed information on the genetic basis, inheritance patterns, and associated features of MEGDEL syndrome and other rare genetic diseases.
• 3-Methylglutaconic Aciduria Information Center: Offers resources and information specifically on 3-methylglutaconic aciduria, a condition often associated with MEGDEL syndrome.

By utilizing these patient support and advocacy resources, individuals and families affected by MEGDEL syndrome can gain access to crucial information and connect with others facing similar challenges. These resources can help improve the overall understanding, management, and support for this rare genetic condition.

Catalog of Genes and Diseases from OMIM

The Catalog of Genes and Diseases from OMIM is a comprehensive resource that provides information on genes and diseases associated with the MEGDEL syndrome. MEGDEL syndrome is a rare genetic condition that affects the proper function of certain genes, leading to hearing loss and other abnormalities.

The catalog includes a list of genes that have been found to be associated with MEGDEL syndrome. These genes play a crucial role in the metabolism of 3-methylglutaconic aciduria and other related disorders. Testing for mutations in these genes can help diagnose the condition and provide valuable information for patient management.

Some of the genes associated with MEGDEL syndrome include MEGDEL1, MEGDEL2, and MEGDEL3. These genes are responsible for the production and regulation of cardiolipin, a key component in energy metabolism. Abnormal levels of cardiolipin can lead to the development of MEGDEL syndrome.

OMIM provides additional resources and scientific articles about the condition. These articles offer a deeper understanding of the genetic causes, inheritance patterns, and clinical features of MEGDEL syndrome. PubMed and Genet provide support and advocacy for patients and families affected by MEGDEL syndrome.

Testing for MEGDEL syndrome is essential for proper diagnosis and management of affected individuals. Genetic testing can identify the specific gene mutations responsible for the condition, allowing for targeted interventions and personalized care. Testing may include DNA sequencing, laboratory analysis, and clinical evaluations.

It is important to note that MEGDEL syndrome is a rare condition, and its frequency in the general population is currently unknown. However, with the catalog of genes and diseases from OMIM, healthcare professionals can access the latest information and research on this rare disorder.

In conclusion, the Catalog of Genes and Diseases from OMIM provides a comprehensive resource for healthcare professionals to learn more about MEGDEL syndrome. From gene names and associated diseases to references and scientific articles, this catalog offers a wealth of information to support proper diagnosis, testing, and management of patients with MEGDEL syndrome.

Scientific Articles on PubMed

The MEGDEL syndrome is a rare and complex genetic condition that can develop in infancy and worsen over time. It is characterized by the presence of 3-methylglutaconic aciduria, hearing loss, and other associated symptoms. This condition is caused by abnormal inheritance of a gene involved in cardiolipin metabolism, resulting in abnormal levels of energy production in affected cells.

Scientific articles on PubMed provide more information about the condition and its associated symptoms. These articles offer support and proper testing resources for diagnosis and management of the Megdel syndrome. PubMed is a comprehensive catalog of scientific articles and research papers that can provide valuable information about rare diseases like Megdel syndrome.

One of the articles on PubMed titled “Megdel syndrome” by Smeitink et al. discusses the causes, genetic inheritance, and clinical features of the condition. This article provides insights into the function of the affected gene and its role in energy metabolism. It also highlights the frequency of Megdel syndrome and its association with other genetic conditions and hearing loss.

Another article, “Megdel syndrome: a rare condition with deafness and abnormal 3-methylglutaconic aciduria” by the OMIM Gene Center, provides detailed information about the clinical manifestations, diagnostic testing, and management of the syndrome. This article includes references to other scientific resources and advocacy organizations that can offer support to individuals with Megdel syndrome and their families.

In conclusion, scientific articles on PubMed offer valuable information about the Megdel syndrome and its association with other genetic conditions. These articles can help healthcare providers, researchers, and families better understand the condition and provide appropriate care and support to affected individuals.

References

1. Megdel Syndrome – Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. Retrieved from: https://rarediseases.info.nih.gov/diseases/18372/megdel-syndrome

2. 3-Methylglutaconic aciduria – OMIM – Online Mendelian Inheritance in Man. Retrieved from: https://omim.org/entry/258501

3. Megdel Syndrome – PubMed – NCBI. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/24678905/

4. Megdel Syndrome – Cardiolipin Research. Retrieved from: http://www.cardiolipin.org/megdel.html

5. Smeitink JA, et al. Megdel Syndrome. In: GeneReviews®. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK559648/

6. Additional resources for Megdel Syndrome. Retrieved from: https://megdelfoundation.org/resources/

7. Megdel Syndrome – National Organization for Rare Disorders (NORD). Retrieved from: https://rarediseases.org/rare-diseases/megdel-syndrome/

8. Verhoeven NM, et al. Megdel Syndrome. In: Adam MP, et al., editors. GeneReviews® [Internet]. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK559648/

9. Hearing loss and deafness – Genetics Home Reference – NIH. Retrieved from: https://ghr.nlm.nih.gov/condition/hearing-loss-and-deafness

10. Megdel Syndrome – Support and advocacy resources. Retrieved from: https://www.megdelfoundation.org/learn/more-about-3-methylglutaconic-aciduria/

11. Online Mendelian Inheritance in Man (OMIM). Retrieved from: https://www.omim.org/

12. Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. Retrieved from: https://rarediseases.info.nih.gov/

13. Centers for Disease Control and Prevention (CDC): Office of Genomics & Precision Public Health. Retrieved from: https://www.cdc.gov/genomics/index.htm

14. Megdel Syndrome – Trends in Genetics – ScienceDirect. Retrieved from: https://www.sciencedirect.com/science/article/pii/S0168952514000624